How much does a low-dose CT lung screening cost privately in the UK? (2026)

A private low-dose CT lung scan is a self-funded screening test for people at higher risk of lung cancer, particularly current and former smokers, designed to find nodules before symptoms appear.

A verified, published price for low-dose CT lung screening was not available to us, so we have left numbers out instead of estimating. The factors and questions below will help you read any quote you are given.

Screening providers usually ask about smoking history and symptoms first, because a person with symptoms needs a diagnostic pathway rather than a screening scan. The scan itself is quick, uses a low radiation dose and needs no injection.

The most important cost question is what happens next. A structured report grades any nodules and sets out when a repeat scan is needed, while a basic report may simply describe them. Ask how repeat scans are priced and who explains the results.

Several things move the cost of low-dose CT lung screening up or down. These are the ones worth asking about first.

• Eligibility checks: providers may assess smoking history and age before scanning, sometimes with a clinician consultation.

• Reporting model: a structured nodule report with a follow-up plan is more expensive than a basic read.

• Annual repeat: screening is repeated over time, so the lifetime cost is multiple scans rather than one.

• The hospital: published one-part CT prices vary by hospital.

• Follow-up of findings: small nodules are common and often require repeat CT, adding cost.

Quotes rarely list everything, so it helps to know what to look for. The table sets out typical inclusions and extras for this procedure.

Insurers rarely cover screening scans without symptoms. If a doctor requests a diagnostic scan for symptoms, cover is more likely.

If you are using insurance, get pre-authorisation in writing before treatment and ask which fees your policy limits could leave uncovered. If you are paying yourself, some hospital groups offer medical finance subject to status; check the rate, term and total repayable before agreeing.

The NHS is rolling out targeted lung cancer screening for people at higher risk, and invites are through GP records, so eligible people may not need to self-fund.

In England the NHS aims to start non-urgent consultant-led treatment within 18 weeks of referral, and patients can ask to be offered alternative providers if that is likely to be exceeded. Actual waits vary by trust and specialty.

No recovery is needed. The main costs that follow are repeat scans and consultations.

Few people need more than the planned care, but the cost position if they do is worth settling before treatment.

• Screening can find nodules that are not cancer, which may lead to repeat scans or procedures; overdiagnosis and false alarms are recognised drawbacks.

• Persistent cough, coughing blood or unexplained weight loss need GP assessment rather than a screening scan, as they may follow the urgent pathway.

When you have two or three estimates, these questions help you see which is genuinely the better value.

• Is the scan a low-dose screening protocol with structured reporting?

• How is a nodule followed up, and who pays?

• Am I eligible for NHS screening instead?

• Does the quote include a clinician review?

• Are professional fees and hospital charges shown as separate lines, and is the total a firm figure or an estimate?